VIVO CAPITAL FUND IX, L.P.
Profile
Company Names
VIVO CAPITAL FUND IX, L.P.
Addresses
192 LYTTON AVENUE, PALO ALTO, CA 94301
505 HAMILTON AVENUE, SUITE 207, PALO ALTO, CA 94301
Phone Numbers
(650) 688-0818
Entity Type:
LIMITED PARTNERSHIP
Industry:
PRIVATE EQUITY FUND
Year Incorporated:
2018
State Incorporated:
DELAWARE
Total Amount Raised:
$1,401,787,761.00
Number of Funding Rounds:
1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2018-08-20
$1,401,787,761.00
$1,401,787,761.00
$0.00
People
First Name
Middle Name
Last Name
Titles
Related Companies
ALBERT
CHA
DIRECTOR
NEOMEND INC
| VICEPT THERAPEUTICS, INC.
| TRIA BEAUTY, INC.
| HEALTH360, INC.
| YAUPON THERAPEUTICS INC
| MEDLEY HEALTH, INC.
| AIRXPANDERS INC
| VIVO VENTURES VII AFFILIATES FUND, L.P.
| CEPTARIS THERAPEUTICS, INC
| ACLARIS THERAPEUTICS, INC.
| CARBYLAN BIOSURGERY, INC
| PRONAI THERAPEUTICS INC
| MINERVA SURGICAL INC
| CARBYLAN THERAPEUTICS, INC.
| ASCENDIS PHARMA A/S
| VIVO CAPITAL FUND VIII, L.P.
| VIVO CAPITAL SURPLUS FUND VIII, L.P.
| MENLO THERAPEUTICS, INC.
| VIVO OPPORTUNITY FUND, L.P.
| VIVO CAPITAL FUND IX, L.P.
| VIVO OPPORTUNITY CO-INVEST, L.P.
| VIVO OPPORTUNITY CO-INVEST (W), L.P.
EDGAR
ENGLEMAN
DIRECTOR
SHAN
FU
DIRECTOR
FRANK
KUNG
DIRECTOR
SAGENT HOLDING CO.
| REVANCE THERAPEUTICS, INC.
| NEXTWAVE PHARMACEUTICALS INC
| VIVO VENTURES VII AFFILIATES FUND, L.P.
| VIVO CAPITAL FUND VIII, L.P.
| VIVO CAPITAL SURPLUS FUND VIII, L.P.
| AMYRIS, INC.
| VIVO OPPORTUNITY FUND, L.P.
| VIVO CAPITAL FUND IX, L.P.
| VIVO OPPORTUNITY CO-INVEST, L.P.
| VIVO OPPORTUNITY CO-INVEST (W), L.P.
| VIVO INNOVATION FUND II, L.P.
| VIVO ASIA OPPORTUNITY FUND, L.P.
| VIVO OPPORTUNITY CAYMAN FUND, L.P.
| VIVO CAPITAL FUND X, L.P.
CHEN
YU
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
CHINA CONCEPT CONSULTING LTD.
NONE
